Aoife Brennan's Net Worth

$530 Thousand

Estimate Recalculated Jun 18, 2025 08:57PM EST

Who is Aoife Brennan

Aoife Brennan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include FIBROGEN INC, SYNLOGIC, INC., Ra Pharmaceuticals, Inc., Xilio Therapeutics, Inc., and Eliem Therapeutics, Inc..

SEC CIK

Aoife Brennan's CIK is 0001714563

Past Insider Trading and Trends

2023 was Aoife Brennan's most active year for acquiring shares with 12 total transactions. Aoife Brennan's most active month to acquire stocks was the month of May. 2023 was Aoife Brennan's most active year for disposing of shares, totalling 13 transactions. Aoife Brennan's most active month to dispose stocks was the month of October. 2024 saw Aoife Brennan paying a total of $0.00 for 945,000 shares, this is the most they've acquired in one year. In 2023 Aoife Brennan cashed out on 170,989 shares for a total of $92,331.22, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

FIBROGEN INC

Investor
Updated Jun 06, 2024
Form 4
70.00K
Jun 06, 2024
70.00K
Grant
Jun 05
Form 4
66.51%
16.22K
$17.19
-$81.37K
Jun 09, 2023
40.61K
Grant
Jun 07 - Jun 09
Form 4
481.32%
41.46K
Jun 21, 2022
50.08K
Grant
Jun 16
Form 4
319.37%
12.50K
May 28, 2021
16.41K
Grant
May 26
Form 4
20.81K
Aug 07, 2020
20.81K
Grant
Aug 05
Form 3
Aug 07, 2020
Showing 6 results

SYNLOGIC, INC.

President and CEO
Updated Nov 14, 2023
Form 4
Nov 14, 2023
147.21K
Acq/Dis
Nov 10
Form 4
-6.92%
-19.04K
$0.58
-$10.96K
Apr 05, 2023
256.30K
Sale
Apr 03
Form 4
-3.13%
-8.89K
$2.45
-$21.75K
Apr 06, 2022
275.34K
Sale
ScheduledApr 04
Form 4
305.15%
541.08K
Feb 08, 2022
718.40K
Grant
Feb 04
Form 4
335.87%
356.25K
Mar 12, 2021
462.32K
Grant
Mar 10
Form 4
387.50%
231.60K
Mar 12, 2020
291.37K
Grant
Mar 10
Form 4
15.45%
8.00K
Sep 25, 2019
59.77K
Grant
Sep 23
Form 4
185.00K
Mar 06, 2019
185.00K
Grant
Mar 05
Form 4
150.00K
Nov 01, 2018
150.00K
Grant
Oct 31
Form 4
54.00K
Jun 06, 2018
54.00K
Grant
Jun 05
Form 4
56.00K
Mar 15, 2018
56.00K
Grant
Mar 14
Form 3
Aug 30, 2017
51.77K
Showing 12 results

Ra Pharmaceuticals, Inc.

Investor
Updated Apr 03, 2020
Form 4
-100.00%
-40.00K
Apr 03, 2020
Disposition
Apr 02
Form 4
15.00K
Jun 13, 2019
15.00K
Grant
Jun 11
Form 4
25.00K
Sep 25, 2018
25.00K
Grant
Sep 21
Form 3
Sep 25, 2018
Showing 4 results

Xilio Therapeutics, Inc.

Investor
Updated Jun 17, 2024
Form 4
50.00K
Jun 17, 2024
50.00K
Grant
Jun 13
Form 3
Jun 17, 2024
Showing 2 results

Eliem Therapeutics, Inc.

President and CEO
Updated Jun 27, 2024
Form 4
825.00K
Jun 27, 2024
825.00K
Grant
Jun 27
Form 3
Jun 27, 2024
Showing 2 results